首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting
【24h】

Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting

机译:前列腺癌研究:下一代; 2019年Coffey-Holden前列腺癌学院会议的报告

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction The 2019 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Prostate Cancer Research: The Next Generation," was held 20 to 23 June, 2019, in Los Angeles, California. Methods The CHPCA Meeting is an annual conference held by the Prostate Cancer Foundation, that is uniquely structured to stimulate intense discussion surrounding topics most critical to accelerating prostate cancer research and the discovery of new life-extending treatments for patients. The 7th Annual CHPCA Meeting was attended by 86 investigators and concentrated on many of the most promising new treatment opportunities and next-generation research technologies. Results The topics of focus at the meeting included: new treatment strategies and novel agents for targeted therapies and precision medicine, new treatment strategies that may synergize with checkpoint immunotherapy, next-generation technologies that visualize tumor microenvironment (TME) and molecular pathology in situ, multi-omics and tumor heterogeneity using single cells, 3D and TME models, and the role of extracellular vesicles in cancer and their potential as biomarkers. Discussion This meeting report provides a comprehensive summary of the talks and discussions held at the 2019 CHPCA Meeting, for the purpose of globally disseminating this knowledge and ultimately accelerating new treatments and diagnostics for patients with prostate cancer.
机译:介绍2019年咖啡持前列腺癌学院(CHPCA)会议,“前列腺癌研究:下一代”,2019年6月20日至23日,在加利福尼亚州洛杉矶举行。方法采用CHPCA会议是前列腺癌基础持有的年度会议,这是独特的构建,以刺激最重要的讨论,最重要的是加速前列腺癌研究以及对患者的新生命延长治疗的发现。 86名调查员参加了第7届年度CHPCA会议,专注于许多最有前途的新治疗机会和下一代研究技术。结果焦点在会议上的主题包括:针对有针对性疗法和精密药物的新治疗策略和新型药剂,可以用检查点免疫疗法,可视化肿瘤微环境(TME)和分子病理原位的下一代技术来协同增长,使用单细胞,3D和TME模型的多OMICS和肿瘤异质性,以及癌细胞囊泡和它们作为生物标志物的潜力的作用。讨论本次会议报告为2019年CHPCA会议举行的会谈和讨论提供了全面的摘要,以便在全球范围内传播这一知识,并最终加速前列腺癌患者的新治疗和诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号